Nour Majbour
Nour Majbour
Qatar Biomedical Research Institute, Hamad Bin Khalifa University
Verified email at hbku.edu.qa - Homepage
TitleCited byYear
Levels of cerebrospinal fluid α-synuclein oligomers are increased in Parkinson’s disease with dementia and dementia with Lewy bodies compared to Alzheimer’s disease
O Hansson, S Hall, A Öhrfelt, H Zetterberg, K Blennow, L Minthon, ...
Alzheimer's research & therapy 6 (3), 25, 2014
1002014
Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson’s disease
NK Majbour, NN Vaikath, KD van Dijk, MT Ardah, S Varghese, ...
Molecular neurodegeneration 11 (1), 7, 2016
882016
Differential role of CSF alpha-synuclein species, tau, and Aβ42 in Parkinson's Disease
L Parnetti, L Farotti, P Eusebi, D Chiasserini, C De Carlo, D Giannandrea, ...
Frontiers in aging neuroscience 6, 53, 2014
862014
Generation and characterization of novel conformation-specific monoclonal antibodies for α-synuclein pathology
NN Vaikath, NK Majbour, KE Paleologou, MT Ardah, E van Dam, ...
Neurobiology of disease 79, 81-99, 2015
562015
Elevated levels of cerebrospinal fluid α-synuclein oligomers in healthy asymptomatic LRRK2 mutation carriers
JO Aasly, KK Johansen, G Brønstad, BJ Warø, NK Majbour, S Varghese, ...
Frontiers in aging neuroscience 6, 248, 2014
392014
Longitudinal changes in CSF alpha‐synuclein species reflect Parkinson's disease progression
NK Majbour, NN Vaikath, P Eusebi, D Chiasserini, M Ardah, S Varghese, ...
Movement Disorders 31 (10), 1535-1542, 2016
382016
Brain propagation of transduced α-synuclein involves non-fibrillar protein species and is enhanced in α-synuclein null mice
M Helwig, M Klinkenberg, R Rusconi, RE Musgrove, NK Majbour, ...
Brain 139 (3), 856-870, 2015
382015
Differential effects of immunotherapy with antibodies targeting α-synuclein oligomers and fibrils in a transgenic model of synucleinopathy
O El-Agnaf, C Overk, E Rockenstein, M Mante, J Florio, A Adame, ...
Neurobiology of disease 104, 85-96, 2017
222017
Lewy body-like alpha-synuclein inclusions trigger reactive microgliosis prior to nigral degeneration
MF Duffy, TJ Collier, JR Patterson, CJ Kemp, KC Luk, MG Tansey, ...
Journal of neuroinflammation 15 (1), 129, 2018
182018
Development of nonviral vectors targeting the brain as a therapeutic approach for Parkinson's disease and other brain disorders
H Javed, SA Menon, KM Al-Mansoori, A Al-Wandi, NK Majbour, MT Ardah, ...
Molecular Therapy 24 (4), 746-758, 2016
172016
Phosphorylated exogenous alpha-synuclein fibrils exacerbate pathology and induce neuronal dysfunction in mice
M Karampetsou, MT Ardah, M Semitekolou, A Polissidis, M Samiotaki, ...
Scientific reports 7 (1), 16533, 2017
162017
Increased levels of CSF total but not oligomeric or phosphorylated forms of alpha-synuclein in patients diagnosed with probable Alzheimer’s disease
NK Majbour, D Chiasserini, NN Vaikath, P Eusebi, T Tokuda, ...
Scientific reports 7, 40263, 2017
142017
A novel multiplex assay for simultaneous quantification of total and S129 phosphorylated human alpha-synuclein
N Landeck, H Hall, MT Ardah, NK Majbour, OMA El-Agnaf, G Halliday, ...
Molecular neurodegeneration 11 (1), 61, 2016
132016
Holocranohistochemistry enables the visualization of α-synuclein expression in the murine olfactory system and discovery of its systemic anti-microbial effects
JJ Tomlinson, B Shutinoski, L Dong, F Meng, D Elleithy, NA Lengacher, ...
Journal of Neural Transmission 124 (6), 721-738, 2017
102017
Ser129 phosphorylation of endogenous α-synuclein induced by overexpression of polo-like kinases 2 and 3 in nigral dopamine neurons is not detrimental to their survival and function
K Buck, N Landeck, A Ulusoy, NK Majbour, OMA El-Agnaf, D Kirik
Neurobiology of disease 78, 100-114, 2015
92015
α‐Synuclein species as potential cerebrospinal fluid biomarkers for dementia with lewy bodies
I van Steenoven, NK Majbour, NN Vaikath, HW Berendse, ...
Movement Disorders 33 (11), 1724-1733, 2018
82018
Heterogeneity in α‐synuclein subtypes and their expression in cortical brain tissue lysates from Lewy body diseases and Alzheimer's disease
NN Vaikath, D Erskine, CM Morris, NK Majbour, K Vekrellis, JY Li, ...
Neuropathology and applied neurobiology, 2018
32018
Cognitive impairment in Parkinson's disease.
N Majbour, O El-Agnaf
The Lancet. Neurology 16 (1), 23, 2017
32017
Parkinson’s disease biomarkers based on α‐synuclein
M Fayyad, S Salim, N Majbour, D Erskine, E Stoops, B Mollenhauer, ...
Journal of neurochemistry, 2019
12019
ALPHA-SYNUCLEIN SPECIES AS POTENTIAL CSF BIOMARKERS FOR DEMENTIA WITH LEWY BODIES
I van Steenoven, NK Majbour, NN Vaikath, HW Berendse, ...
Alzheimer's & Dementia: The Journal of the Alzheimer's Association 13 (7), P338, 2017
12017
The system can't perform the operation now. Try again later.
Articles 1–20